Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617 1632 1648 1671 1672
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17925966 | IMMUNOGENIC COMPOSITIONS AND USES THEREOF | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 18452524 | CONFORMATIONAL EPITOPES IN RESPIRATORY SYNCYTIAL VIRUS G PROTEIN CENTRAL CONSERVED REGION | Final Rejection | The Regents of the University of California |
| 18655408 | POLYNUCLEOTIDES ENCODING NOROVIRUS VP1 ANTIGENS AND USES THEREOF | Non-Final OA | Merck Sharp & Dohme LLC |
| 18411568 | Ferritin Proteins | Final Rejection | SANOFI |
| 18493936 | Methods of Treatment of High-Grade Squamous Intraepithelial Lesion (HSIL) | Non-Final OA | Inovio Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy